Aura Biosciences, Inc. (AURA): Price and Financial Metrics
AURA Price/Volume Stats
Current price | $10.33 | 52-week high | $12.38 |
Prev. close | $10.65 | 52-week low | $6.63 |
Day low | $10.30 | Volume | 117,500 |
Day high | $11.04 | Avg. volume | 175,508 |
50-day MA | $9.75 | Dividend yield | N/A |
200-day MA | $8.37 | Market Cap | 512.43M |
AURA Stock Price Chart Interactive Chart >
Aura Biosciences, Inc. (AURA) Company Bio
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform to treat tumors of high unmet need in ocular and urologic oncology. Its AU-011, a VDC candidate, is being developed for the first line treatment of primary choroidal melanoma, a rare disease with no drugs approved. The company also develops AU-011 in additional ocular oncology indications, including choroidal metastases. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.
AURA Price Returns
1-mo | 4.77% |
3-mo | 31.09% |
6-mo | 42.09% |
1-year | 27.69% |
3-year | -50.10% |
5-year | N/A |
YTD | 16.59% |
2023 | -15.62% |
2022 | -38.16% |
2021 | N/A |
2020 | N/A |
2019 | N/A |
Loading social stream, please wait...